Trials / Conditions / Lung Non-Small Cell Squamous Carcinoma
Lung Non-Small Cell Squamous Carcinoma
4 registered clinical trials studyying Lung Non-Small Cell Squamous Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin NCT04216316 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small NCT04267848 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent NCT03845296 | SWOG Cancer Research Network | Phase 2 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurre NCT03110978 | M.D. Anderson Cancer Center | Phase 2 |